UNISOM
Pronunciation: dox-IL-a-meen


What it isFirst-generation H1 antagonist; insomnia, and with pyridoxine for nausea of pregnancy.
Why this onePyridoxine combination is the only FDA-approved treatment for nausea and vomiting of pregnancy.
What limits itAnticholinergic burden and next-day sedation. Tolerance to the hypnotic effect develops quickly.
Animated chart of estimated U.S. prescriptions per year, H1 antihistamines (1944–2026). Doxylamine enters in 1949 (estimated).
Principal riskAnticholinergic burden and next-day sedation
Defining liabilityResidual sedation and antimuscarinic effects
Read the full label on DailyMed ↗
NO BOXED WARNINGS
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Insomnia (OTC nighttime sleep aid) | Adults & children ≥12 y | 1 tablet QHS PRN | 1 tablet QHS | 1 tablet/day |
Renal Undefined
Hepatic Undefined
Available strengths
Pregnancy Undefined
Lactation Undefined
| Strength | #/mo | generic $/unit | CostPlus | |
|---|---|---|---|---|
| 25 mg | tab | per unit | $0.12/ea | not offered |
Open Doxylamine in the interactive console ↗

Open Doxylamine in the interactive console ↗